Psomagen (XKRX:950200) Operating Cash Flow per Share : ₩48.11 (TTM As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Psomagen Operating Cash Flow per Share?

Psomagen's operating cash flow per share for the three months ended in Mar. 2024 was ₩-5.86. Psomagen's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2024 was ₩48.11.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Psomagen was -71.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Psomagen's Operating Cash Flow per Share or its related term are showing as below:

During the past 6 years, Psomagen's highest 3-Year average Operating Cash Flow per Share Growth Rate was 55.40% per year. The lowest was 55.40% per year. And the median was 55.40% per year.

XKRX:950200's 3-Year OCF Growth Rate is not ranked ^*
in the Medical Diagnostics & Research industry.
Industry Median: 1.4
* Ranked among companies with meaningful 3-Year OCF Growth Rate only.

Psomagen Operating Cash Flow per Share Historical Data

The historical data trend for Psomagen's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Psomagen Operating Cash Flow per Share Chart

Psomagen Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Operating Cash Flow per Share

Get a 7-Day Free Trial

-161.64

-299.91

-291.23

-14.32

82.29

Psomagen Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Operating Cash Flow per Share	Get a 7-Day Free Trial														34.19	31.78	-16.95	39.14	-5.86

Competitive Comparison of Psomagen's Operating Cash Flow per Share

For the Diagnostics & Research subindustry, Psomagen's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Psomagen's Price-to-Operating-Cash-Flow Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Psomagen's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Psomagen's Price-to-Operating-Cash-Flow falls into.

Psomagen Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Psomagen's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )	=	Cash Flow from Operations (A: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2023 )
	=	1589.58	/	19.317
	=	82.29

Psomagen's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Mar. 2024 )	=	Cash Flow from Operations (Q: Mar. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Mar. 2024 )
	=	-108.606	/	18.535
	=	-5.86

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩48.11

Psomagen Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Psomagen's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Psomagen (XKRX:950200) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Psomagen Inc (XKRX:950200) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

1330 Piccard Drive, Suite 103, Rockville, MD, USA, 20850

Website

https://www.psomagen.com

Psomagen Inc, formerly Macrogen Corp provides total genomic solutions for both clinical and research purposes. It is mainly focused on end-to-end sequencing services. The company also offers services such as personal DNA tests, clinical sequencing, research sequencing, and others.

Psomagen (XKRX:950200) Headlines

No Headlines